• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . 'Long COVID': persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2021 Mar 25;21(1):304.
doi: 10.1186/s12879-020-05716-x.
'Long COVID': persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria


Bodunrin Osikomaiya[SUP] 1 [/SUP], Olufemi Erinoso[SUP] 2 [/SUP], Kikelomo Ololade Wright[SUP] 3 [/SUP], Aina Olufemi Odusola[SUP] 3 [/SUP], Babafemi Thomas[SUP] 4 [/SUP], Oluwatosin Adeyemi[SUP] 3 [/SUP], Abimbola Bowale[SUP] 5 [/SUP], Olusola Adejumo[SUP] 5 [/SUP], Ayodeji Falana[SUP] 5 [/SUP], Ismail Abdus-Salam[SUP] 6 [/SUP], Olusegun Ogboye[SUP] 6 [/SUP], Akin Osibogun[SUP] 7 [/SUP], Akin Abayomi[SUP] 6 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease once thought to be a respiratory infection is now recognised as a multi-system disease affecting the respiratory, cardiovascular, gastrointestinal, neurological, immune, and hematopoietic systems. An emerging body of evidence suggests the persistence of COVID-19 symptoms of varying patterns among some survivors. This study aimed to describe persistent symptoms in COVID-19 survivors and investigate possible risk factors for these persistent symptoms.
Methods: The study used a retrospective study design. The study population comprised of discharged COVID-19 patients. Demographic information, days since discharge, comorbidities, and persistent COVID-19 like symptoms were assessed in patients attending the COVID-19 outpatient clinic in Lagos State. Statistical analysis was done using STATA 15.0 software (StataCorp Texas) with significance placed at p-value < 0.05.
Results: A total of 274 patients were enrolled in the study. A majority were within the age group > 35 to ?49 years (38.3%), and male (66.1%). More than one-third (40.9%) had persistent COVID-19 symptoms after discharge, and 19.7% had more than three persistent COVID-like symptoms. The most persistent COVID-like symptoms experienced were easy fatigability (12.8%), headaches (12.8%), and chest pain (9.8%). Symptomatic COVID-19 disease with moderate severity compared to mild severity was a predictor of persistent COVID-like symptoms after discharge (p < 0.05).
Conclusion: Findings from this study suggests that patients who recovered from COVID-19 disease may still experience COVID-19 like symptoms, particularly fatigue and headaches. Therefore, careful monitoring should be in place after discharge to help mitigate the effects of these symptoms and improve the quality of life of COVID-19 survivors.

Keywords: COVID-19; Persistent symptoms; Survivors.
 
Back
Top Bottom